James Roth is a University Professor in Shenzhen, China for over 9 years now. In May, he had a slip and fall accident while walking and unfortunately broke his right wrist. He knew that he needed medical attention and went straight to the The University of Hong Kong-Shenzhen Hospital to have himself checked. His initial thought on his accident that something was just dislocated in his wrist but apparently he needed to be admitted to the hospital. After undergoing x-rays and tests, the doctor consulted him about placing titanium plates on his wrist. Find out more of his hospital experiences and his current condition after the surgery.
Thank you for listening. We would appreciate your comments and reviews.
In This Episode, You’ll Learn
- How James had caught in an accident and broke his wrist
- About his experiences in the hospital where he was admitted to
- How his doctor consulted him about inserting titanium plates into his wrist
- About the overall cost he spent for the surgery
- How he compared the cost of Chinese titanium plates versus the US ones
- About his impressions toward people, facilities and procedures in the hospital
- About his travels to other Asian countries
- About his best pieces of advice for International patients who plan to travel around Southeast Asia
- The University of Hong Kong-Shenzhen Hospital website – where James was admitted
- Shenzhen University – where James is working as a professor in English and Writing.
- James’ Non fiction Short Story
The Onwards Medical Breakthrough
Studies reveal potential new targeted therapies for common, hard-to-treat cancers
“Positive results from four clinical trials of investigational targeted drugs for advanced ovarian, lung, and thyroid cancers, and chronic lymphocytic leukemia were highlighted today at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO). Findings from the mid- and late-stage trials suggest new ways to slow disease progression and improve survival for patients who experience relapses or resistance to available treatments.
“Cancer relapses and treatment resistance have always been among the most daunting challenges in cancer care,” said press briefing moderator Gregory Masters, MD, FACP, ASCO Expert and a medical oncologist at the Helen F. Graham Cancer Center in Newark, Delaware. “The good news is that genomic medicine is helping to overcome these challenges by revealing new ways to target a cancer cell’s inner workings. The research highlighted today could lead to new treatment options forpatients who, until now, have had none, or for whom the side effects of current drugs outweigh their limited benefits, as we often see with our older patients with leukemia.”
You can learn more about this discovery at this link.